New hope for tough seizures: Real-World data on cenobamate

NCT ID NCT05859854

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times

Summary

This study collects information from over 900 adults in Italy whose focal seizures are not controlled by at least two other seizure medicines. Researchers are tracking how well cenobamate reduces seizure frequency and how safe it is in everyday medical practice. The goal is to better understand the drug's real-world benefits and risks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Associazione La Nostra Famiglia - IRCCS Eugenio Medea

    Conegliano, Treviso, 31015, Italy

  • Azienda Sanitaria Universitaria (A.O.U.) Integrata

    Udine, Udine, 33100, Italy

  • Campus Bio-Medico

    Roma, Roma, 00128, Italy

  • Fondazione Istituto Neurologico Casimiro Mondino

    Pavia, Pavia, 27100, Italy

  • Humanitas Gradenigo

    Torino, Torino, 10153, Italy

  • IRCCS Neuromed

    Pozzilli, Isernia, 86077, Italy

  • Ospedale San Bortolo

    Vicenza, Vicenza, 36100, Italy

  • Policlinico Umberto I

    Roma, Roma, 00161, Italy

  • Policlinico di Bari

    Bari, Bari, 70124, Italy

  • Università degli Studi di Catanzaro "Magna Graecia"

    Catanzaro, Catanzaro, 88100, Italy

Conditions

Explore the condition pages connected to this study.